Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Rigid Uretero Scopes Market by  Product Type (2mm, 3mm, Others) and by End User (Hospitals, Clinics, Ambulatory Surgical Centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

A13417

Pages: NA

Charts: NA

Tables: NA

Rigid ureteroscopy is a treatment for stones in the ureter. In this procedure, a thin telescope is inserted through your urethra under general anesthesia, which gives a path to the ureter. Once the stone is detected then it can be fragmented using a laser. The resultant fragments are then either removed with a fine basket-type device used to pick up any larger pieces or washed like dust. The method often also includes the insertion of a soft plastic tube (stent) between the bladder and kidney and the use of x-rays. This makes sure drainage of urine from the kidney to confirm stone fragments can pass smoothly.

COVID-19 Impact analysis

COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

There has been an increase in the demand for medical supplies to take care of infected population. Respiratory support devices such as atomizers, life-support machines, oxygen generators, and monitors are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. There is an increase in the need for medical supplies, both from healthcare professionals and civil population for precautionary measures, owing to the rise in number of COVID-19 cases worldwide. Manufacturers of these products have a chance to capitalize this increased demand for medical supplies to ensure adequate and continuous supply of personal protective equipment in the market. Therefore, COVID 19 is expected to have a significant impact on the rigid uretero scopes market.

Top Impacting Factors

  • Increase in cases of renal diseases, surge in geriatric populations, and rise in demand for minimally invasive procedures & advanced renal treatment and procedures are the factors that drive the growth of the rigid uretero scopes market.
  • In addition, increase in healthcare expenditure; availability of skilled professionals; rise in R&D activities to develop and launch novel devices in the market; and technological advancements, are some factors, which boost the market growth for rigid uretero scopes.
  • However, the availability of alternative therapies such as shock wave therapy and a percutaneous surgery, and the high cost of ureteroscopy procedures hinder the market growth.

Rigid Uretero Scopes Market Trends

New product launches to flourish the market

In March 2018, Olympus Medical Systems Corp. received U.S FDA approval for the company's URF-V2/V2R ureteroscope meant for endoscopy of ureter and kidney.

Key Benefits of the Report

  • This study presents the analytical depiction of the rigid uretero scopes industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the rigid uretero scopes market share.
  • The current market is quantitatively analyzed to highlight the rigid uretero scopes market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed rigid uretero scopes market analysis based on competitive intensity and how the competition will take shape in coming years

Questions answered in the rigid uretero scopes Report

  • Which are the leading players active in the rigid uretero scopes angioplasty balloons market?
  • What are the current trends that will influence the rigid uretero scopes market in the next few years?
  • What are the driving factors, restraints, and opportunities of the rigid uretero scopes market?
  • What future projections would help in taking further strategic steps?
  • What is "Rigid uretero scopes"?
  • What is "Rigid uretero scopes" Market prediction in the future?
  • Who are the leading global players in the "Rigid uretero scopes" Market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the "Rigid uretero scopes" Market report?

 Key Market Segments

  • By  Product Type
    • 2mm
    • 3mm
    • Others
  • By End User
    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • HOYA
  • Elmed Medical Systems
  • Olympus
  • Boston Scientific
  • Maxer Endoscopy
  • Stryker
  • Richard Wolf
  • Karl Storz
  • Rocamed
  • Vimex Endoscopy

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: RIGID URETERO SCOPES MARKET, BY  PRODUCT TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By  product Type

    • 4.2. 2mm

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. 3mm

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Others

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: RIGID URETERO SCOPES MARKET, BY END USER

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By End User

    • 5.2. Hospitals

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Clinics

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Ambulatory Surgical Centers

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Others

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: RIGID URETERO SCOPES MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By  product Type

      • 6.2.3. Market Size and Forecast, By End User

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Rigid Uretero Scopes Market

        • 6.2.5.1. Market Size and Forecast, By  product Type
        • 6.2.5.2. Market Size and Forecast, By End User

      • 6.2.6. Canada Rigid Uretero Scopes Market

        • 6.2.6.1. Market Size and Forecast, By  product Type
        • 6.2.6.2. Market Size and Forecast, By End User

      • 6.2.7. Mexico Rigid Uretero Scopes Market

        • 6.2.7.1. Market Size and Forecast, By  product Type
        • 6.2.7.2. Market Size and Forecast, By End User

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By  product Type

      • 6.3.3. Market Size and Forecast, By End User

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Rigid Uretero Scopes Market

        • 6.3.5.1. Market Size and Forecast, By  product Type
        • 6.3.5.2. Market Size and Forecast, By End User

      • 6.3.6. Germany Rigid Uretero Scopes Market

        • 6.3.6.1. Market Size and Forecast, By  product Type
        • 6.3.6.2. Market Size and Forecast, By End User

      • 6.3.7. Italy Rigid Uretero Scopes Market

        • 6.3.7.1. Market Size and Forecast, By  product Type
        • 6.3.7.2. Market Size and Forecast, By End User

      • 6.3.8. Spain Rigid Uretero Scopes Market

        • 6.3.8.1. Market Size and Forecast, By  product Type
        • 6.3.8.2. Market Size and Forecast, By End User

      • 6.3.9. UK Rigid Uretero Scopes Market

        • 6.3.9.1. Market Size and Forecast, By  product Type
        • 6.3.9.2. Market Size and Forecast, By End User

      • 6.3.10. Russia Rigid Uretero Scopes Market

        • 6.3.10.1. Market Size and Forecast, By  product Type
        • 6.3.10.2. Market Size and Forecast, By End User

      • 6.3.11. Rest Of Europe Rigid Uretero Scopes Market

        • 6.3.11.1. Market Size and Forecast, By  product Type
        • 6.3.11.2. Market Size and Forecast, By End User

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By  product Type

      • 6.4.3. Market Size and Forecast, By End User

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Rigid Uretero Scopes Market

        • 6.4.5.1. Market Size and Forecast, By  product Type
        • 6.4.5.2. Market Size and Forecast, By End User

      • 6.4.6. Japan Rigid Uretero Scopes Market

        • 6.4.6.1. Market Size and Forecast, By  product Type
        • 6.4.6.2. Market Size and Forecast, By End User

      • 6.4.7. India Rigid Uretero Scopes Market

        • 6.4.7.1. Market Size and Forecast, By  product Type
        • 6.4.7.2. Market Size and Forecast, By End User

      • 6.4.8. South Korea Rigid Uretero Scopes Market

        • 6.4.8.1. Market Size and Forecast, By  product Type
        • 6.4.8.2. Market Size and Forecast, By End User

      • 6.4.9. Australia Rigid Uretero Scopes Market

        • 6.4.9.1. Market Size and Forecast, By  product Type
        • 6.4.9.2. Market Size and Forecast, By End User

      • 6.4.10. Thailand Rigid Uretero Scopes Market

        • 6.4.10.1. Market Size and Forecast, By  product Type
        • 6.4.10.2. Market Size and Forecast, By End User

      • 6.4.11. Malaysia Rigid Uretero Scopes Market

        • 6.4.11.1. Market Size and Forecast, By  product Type
        • 6.4.11.2. Market Size and Forecast, By End User

      • 6.4.12. Indonesia Rigid Uretero Scopes Market

        • 6.4.12.1. Market Size and Forecast, By  product Type
        • 6.4.12.2. Market Size and Forecast, By End User

      • 6.4.13. Rest of Asia Pacific Rigid Uretero Scopes Market

        • 6.4.13.1. Market Size and Forecast, By  product Type
        • 6.4.13.2. Market Size and Forecast, By End User

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By  product Type

      • 6.5.3. Market Size and Forecast, By End User

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Rigid Uretero Scopes Market

        • 6.5.5.1. Market Size and Forecast, By  product Type
        • 6.5.5.2. Market Size and Forecast, By End User

      • 6.5.6. South Africa Rigid Uretero Scopes Market

        • 6.5.6.1. Market Size and Forecast, By  product Type
        • 6.5.6.2. Market Size and Forecast, By End User

      • 6.5.7. Saudi Arabia Rigid Uretero Scopes Market

        • 6.5.7.1. Market Size and Forecast, By  product Type
        • 6.5.7.2. Market Size and Forecast, By End User

      • 6.5.8. UAE Rigid Uretero Scopes Market

        • 6.5.8.1. Market Size and Forecast, By  product Type
        • 6.5.8.2. Market Size and Forecast, By End User

      • 6.5.9. Argentina Rigid Uretero Scopes Market

        • 6.5.9.1. Market Size and Forecast, By  product Type
        • 6.5.9.2. Market Size and Forecast, By End User

      • 6.5.10. Rest of LAMEA Rigid Uretero Scopes Market

        • 6.5.10.1. Market Size and Forecast, By  product Type
        • 6.5.10.2. Market Size and Forecast, By End User

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Stryker

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Olympus

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Boston Scientific

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Richard Wolf

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Karl Storz

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. HOYA

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Elmed Medical Systems

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Maxer Endoscopy

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Rocamed

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Vimex Endoscopy

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL RIGID URETERO SCOPES MARKET, BY  PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL RIGID URETERO SCOPES MARKET FOR 2MM, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL RIGID URETERO SCOPES MARKET FOR 3MM, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL RIGID URETERO SCOPES MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL RIGID URETERO SCOPES MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL RIGID URETERO SCOPES MARKET FOR HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL RIGID URETERO SCOPES MARKET FOR CLINICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL RIGID URETERO SCOPES MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL RIGID URETERO SCOPES MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL RIGID URETERO SCOPES MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. NORTH AMERICA RIGID URETERO SCOPES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. NORTH AMERICA RIGID URETERO SCOPES, BY  PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 13. NORTH AMERICA RIGID URETERO SCOPES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 14. U.S. RIGID URETERO SCOPES, BY  PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 15. U.S. RIGID URETERO SCOPES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 16. CANADA RIGID URETERO SCOPES, BY  PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 17. CANADA RIGID URETERO SCOPES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 18. MEXICO RIGID URETERO SCOPES, BY  PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 19. MEXICO RIGID URETERO SCOPES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 20. EUROPE RIGID URETERO SCOPES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 21. EUROPE RIGID URETERO SCOPES, BY  PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 22. EUROPE RIGID URETERO SCOPES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 23. FRANCE RIGID URETERO SCOPES, BY  PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 24. FRANCE RIGID URETERO SCOPES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 25. GERMANY RIGID URETERO SCOPES, BY  PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 26. GERMANY RIGID URETERO SCOPES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 27. ITALY RIGID URETERO SCOPES, BY  PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 28. ITALY RIGID URETERO SCOPES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 29. SPAIN RIGID URETERO SCOPES, BY  PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 30. SPAIN RIGID URETERO SCOPES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 31. UK RIGID URETERO SCOPES, BY  PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 32. UK RIGID URETERO SCOPES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 33. RUSSIA RIGID URETERO SCOPES, BY  PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 34. RUSSIA RIGID URETERO SCOPES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 35. REST OF EUROPE RIGID URETERO SCOPES, BY  PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 36. REST OF EUROPE RIGID URETERO SCOPES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 37. ASIA-PACIFIC RIGID URETERO SCOPES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 38. ASIA-PACIFIC RIGID URETERO SCOPES, BY  PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 39. ASIA-PACIFIC RIGID URETERO SCOPES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 40. CHINA RIGID URETERO SCOPES, BY  PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 41. CHINA RIGID URETERO SCOPES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 42. JAPAN RIGID URETERO SCOPES, BY  PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 43. JAPAN RIGID URETERO SCOPES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 44. INDIA RIGID URETERO SCOPES, BY  PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 45. INDIA RIGID URETERO SCOPES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 46. SOUTH KOREA RIGID URETERO SCOPES, BY  PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 47. SOUTH KOREA RIGID URETERO SCOPES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 48. AUSTRALIA RIGID URETERO SCOPES, BY  PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 49. AUSTRALIA RIGID URETERO SCOPES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 50. THAILAND RIGID URETERO SCOPES, BY  PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 51. THAILAND RIGID URETERO SCOPES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 52. MALAYSIA RIGID URETERO SCOPES, BY  PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 53. MALAYSIA RIGID URETERO SCOPES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 54. INDONESIA RIGID URETERO SCOPES, BY  PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 55. INDONESIA RIGID URETERO SCOPES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 56. REST OF ASIA PACIFIC RIGID URETERO SCOPES, BY  PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 57. REST OF ASIA PACIFIC RIGID URETERO SCOPES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 58. LAMEA RIGID URETERO SCOPES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 59. LAMEA RIGID URETERO SCOPES, BY  PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 60. LAMEA RIGID URETERO SCOPES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 61. BRAZIL RIGID URETERO SCOPES, BY  PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 62. BRAZIL RIGID URETERO SCOPES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 63. SOUTH AFRICA RIGID URETERO SCOPES, BY  PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 64. SOUTH AFRICA RIGID URETERO SCOPES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 65. SAUDI ARABIA RIGID URETERO SCOPES, BY  PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 66. SAUDI ARABIA RIGID URETERO SCOPES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 67. UAE RIGID URETERO SCOPES, BY  PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 68. UAE RIGID URETERO SCOPES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 69. ARGENTINA RIGID URETERO SCOPES, BY  PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 70. ARGENTINA RIGID URETERO SCOPES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 71. REST OF LAMEA RIGID URETERO SCOPES, BY  PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 72. REST OF LAMEA RIGID URETERO SCOPES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 73. STRYKER: KEY EXECUTIVES
  • TABLE 74. STRYKER: COMPANY SNAPSHOT
  • TABLE 75. STRYKER: OPERATING SEGMENTS
  • TABLE 76. STRYKER: PRODUCT PORTFOLIO
  • TABLE 77. STRYKER: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 78. OLYMPUS: KEY EXECUTIVES
  • TABLE 79. OLYMPUS: COMPANY SNAPSHOT
  • TABLE 80. OLYMPUS: OPERATING SEGMENTS
  • TABLE 81. OLYMPUS: PRODUCT PORTFOLIO
  • TABLE 82. OLYMPUS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 83. BOSTON SCIENTIFIC: KEY EXECUTIVES
  • TABLE 84. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
  • TABLE 85. BOSTON SCIENTIFIC: OPERATING SEGMENTS
  • TABLE 86. BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
  • TABLE 87. BOSTON SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 88. RICHARD WOLF: KEY EXECUTIVES
  • TABLE 89. RICHARD WOLF: COMPANY SNAPSHOT
  • TABLE 90. RICHARD WOLF: OPERATING SEGMENTS
  • TABLE 91. RICHARD WOLF: PRODUCT PORTFOLIO
  • TABLE 92. RICHARD WOLF: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 93. KARL STORZ: KEY EXECUTIVES
  • TABLE 94. KARL STORZ: COMPANY SNAPSHOT
  • TABLE 95. KARL STORZ: OPERATING SEGMENTS
  • TABLE 96. KARL STORZ: PRODUCT PORTFOLIO
  • TABLE 97. KARL STORZ: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 98. HOYA: KEY EXECUTIVES
  • TABLE 99. HOYA: COMPANY SNAPSHOT
  • TABLE 100. HOYA: OPERATING SEGMENTS
  • TABLE 101. HOYA: PRODUCT PORTFOLIO
  • TABLE 102. HOYA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 103. ELMED MEDICAL SYSTEMS: KEY EXECUTIVES
  • TABLE 104. ELMED MEDICAL SYSTEMS: COMPANY SNAPSHOT
  • TABLE 105. ELMED MEDICAL SYSTEMS: OPERATING SEGMENTS
  • TABLE 106. ELMED MEDICAL SYSTEMS: PRODUCT PORTFOLIO
  • TABLE 107. ELMED MEDICAL SYSTEMS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 108. MAXER ENDOSCOPY: KEY EXECUTIVES
  • TABLE 109. MAXER ENDOSCOPY: COMPANY SNAPSHOT
  • TABLE 110. MAXER ENDOSCOPY: OPERATING SEGMENTS
  • TABLE 111. MAXER ENDOSCOPY: PRODUCT PORTFOLIO
  • TABLE 112. MAXER ENDOSCOPY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 113. ROCAMED: KEY EXECUTIVES
  • TABLE 114. ROCAMED: COMPANY SNAPSHOT
  • TABLE 115. ROCAMED: OPERATING SEGMENTS
  • TABLE 116. ROCAMED: PRODUCT PORTFOLIO
  • TABLE 117. ROCAMED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 118. VIMEX ENDOSCOPY: KEY EXECUTIVES
  • TABLE 119. VIMEX ENDOSCOPY: COMPANY SNAPSHOT
  • TABLE 120. VIMEX ENDOSCOPY: OPERATING SEGMENTS
  • TABLE 121. VIMEX ENDOSCOPY: PRODUCT PORTFOLIO
  • TABLE 122. VIMEX ENDOSCOPY: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL RIGID URETERO SCOPES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL RIGID URETERO SCOPES MARKET
  • FIGURE 3. SEGMENTATION RIGID URETERO SCOPES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN RIGID URETERO SCOPES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALRIGID URETERO SCOPES MARKET
  • FIGURE 11. RIGID URETERO SCOPES MARKET SEGMENTATION, BY BY  PRODUCT TYPE
  • FIGURE 12. RIGID URETERO SCOPES MARKET FOR 2MM, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. RIGID URETERO SCOPES MARKET FOR 3MM, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. RIGID URETERO SCOPES MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. RIGID URETERO SCOPES MARKET SEGMENTATION, BY BY END USER
  • FIGURE 16. RIGID URETERO SCOPES MARKET FOR HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. RIGID URETERO SCOPES MARKET FOR CLINICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. RIGID URETERO SCOPES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. RIGID URETERO SCOPES MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 21. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 22. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 23. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 24. COMPETITIVE DASHBOARD
  • FIGURE 25. COMPETITIVE HEATMAP: RIGID URETERO SCOPES MARKET
  • FIGURE 26. TOP PLAYER POSITIONING, 2024
  • FIGURE 27. STRYKER: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 28. STRYKER: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 29. STRYKER: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 30. OLYMPUS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 31. OLYMPUS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 32. OLYMPUS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 33. BOSTON SCIENTIFIC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 34. BOSTON SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 35. BOSTON SCIENTIFIC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 36. RICHARD WOLF: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 37. RICHARD WOLF: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 38. RICHARD WOLF: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 39. KARL STORZ: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 40. KARL STORZ: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 41. KARL STORZ: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 42. HOYA: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 43. HOYA: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 44. HOYA: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 45. ELMED MEDICAL SYSTEMS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 46. ELMED MEDICAL SYSTEMS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 47. ELMED MEDICAL SYSTEMS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 48. MAXER ENDOSCOPY: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 49. MAXER ENDOSCOPY: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 50. MAXER ENDOSCOPY: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 51. ROCAMED: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 52. ROCAMED: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 53. ROCAMED: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 54. VIMEX ENDOSCOPY: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 55. VIMEX ENDOSCOPY: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 56. VIMEX ENDOSCOPY: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Rigid Uretero Scopes Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved